Page 38 - Influenza Report
P. 38

38   Influenza


                           75.  Li KS, Guan Y, Wang J, et al. Genesis of a highly pathogenic and potentially pandemic
                           H5N1 influenza virus in eastern Asia. Nature 2004; 430: 209-13. Abstract:
                           http://amedeo.com/lit.php?id=15241415
                           76.  Li S, Schulman J, Itamura S, Palese P. Glycosylation of neuraminidase determines the
                           neurovirulence of influenza A/WSN/33 virus. J Virol 1993; 67: 6667-73. Abstract:
                           http://amedeo.com/lit.php?id=8411368 – Full text at
                           http://www.pubmedcentral.gov/articlerender.fcgi?pubmedid=8411368
                           77.  Lokuge B, Drahos P, Neville W. Pandemics, antiviral stockpiles and biosecurity in
                           Australia: what about the generic option? Med J Aust 2006; 184: 16-20. Abstract:
                           http://amedeo.com/lit.php?id=16398625 – Full text at
                           http://www.mja.com.au/public/issues/184_01_020106/lok10852_fm.html
                           78.  Longini IM Jr, Nizam A, Xu S, et al. Containing pandemic influenza at the source. Science
                           2005; 309: 1083-7. Epub 2005 Aug 3. Abstract: http://amedeo.com/lit.php?id=16079251
                           79.  Louria DB, Blumenfeld HL, Ellis JT, Kilbourne ED, Rogers DE. Studies on influenza in the
                           pandemic of 1957-1958. II. Pulmonary complications of influenza. J Clin Invest 1959; 38: 213-
                           65. Full text at http://www.pubmedcentral.gov/articlerender.fcgi?pubmedid=13620784
                           80.  Ma KK, Schaffner W, Colmenares C, Howser J, Jones J, Poehling KA. Influenza
                           vaccinations of young children increased with media coverage in 2003. Pediatrics 2006; 117:
                           Abstract: http://amedeo.com/lit.php?id=16452325
                           81.  Maines TR, Lu XH, Erb SM, et al. Avian influenza (H5N1) viruses isolated from humans in
                           Asia in 2004 exhibit increased virulence in mammals. J Virol 2005; 79: 11788-800. Abstract:
                           http://amedeo.com/lit.php?id=16140756
                           82.  Matrosovich M, Tuzikov A, Bovin N, et al. Early alterations of the receptor-binding
                           properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into
                           mammals. J Virol 2000; 74: 8502-12. Abstract: http://amedeo.com/lit.php?id=10954551 – Full
                           text at http://jvi.asm.org/cgi/content/full/74/18/8502
                           83.  Monto AS, Fleming DM, Henry D, et al. Efficacy and safety of the neuraminidase inhibitor
                           zanamivir in the treatment of influenza A and B virus infections. J Infect Dis 1999; 180: 254-61.
                           Abstract: http://amedeo.com/lit.php?id=10395837 – Full text at
                           http://www.journals.uchicago.edu/JID/journal/issues/v180n2/990003/990003.html
                           84.  Monto AS, Robinson DP, Herlocher ML, Hinson JM Jr, Elliott MJ, Crisp A. Zanamivir in the
                           prevention of influenza among healthy adults: a randomized controlled trial. JAMA 1999; 282:
                           31-5. Abstract: http://amedeo.com/lit.php?id=10404908  – Full text at http://jama.ama-
                           assn.org/cgi/content/abstract/282/1/31
                           85.  Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med 2005; 353: 1363-73.
                           http://amedeo.com/lit.php?id=16192481 – Full text at
                           http://content.nejm.org/cgi/content/full/353/13/1363
                           86.  Neirynck S, Deroo T, Saelens X, Vanlandschoot P, Jou WM, Fiers W. A universal
                           influenza A vaccine based on the extracellular domain of the M2 protein. Nat Med 1999; 5:
                           1157-63. Abstract: http://amedeo.com/lit.php?id=10502819
                           87.  Nicholson KG, Aoki FY, Osterhaus AD, et al. Efficacy and safety of oseltamivir in
                           treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu
                           Treatment Investigator Group. Lancet 2000; 355: 1845-50. Abstract:
                           http://amedeo.com/lit.php?id=10866439
                           88.  Nicholson KG, Wood JM, Zambon M. Influenza. Lancet 2003; 362: 1733-45. Abstract:
                           http://amedeo.com/lit.php?id=14643124
                           89.  Noah DL, Krug RM. Influenza virus virulence and its molecular determinants. Adv Virus
                           Res 2005; 65: 121-45. http://amedeo.com/lit.php?id=16387195
                           90.  Noda T, Sagara H, Yen A, et al. Architecture of ribonucleoprotein complexes in influenza
                           A virus particles. Nature 2006; 439: 490-492. Abstract: http://amedeo.com/lit.php?id=16437116
                           91.  Obenauer JC, Denson J, Mehta PK, et al. Large-scale sequence analysis of avian
                           influenza isolates. Science 2006; 311: 1576-80. Epub 2006 Jan 26. Abstract:
                           http://amedeo.com/lit.php?id=16439620
                           92.  Olson DR, Simonsen L, Edelson PJ, Morse SS. Epidemiological evidence of an early
                           wave of the 1918 influenza pandemic in New York City. Proc Natl Acad Sci U S A 2005; 102:
   33   34   35   36   37   38   39   40   41   42   43